Foreign Experts Assess Benefits Of Russia’s Sputnik V Coronavirus Vaccine – Analysis

Eurasia Review


The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that the Sputnik V vaccine demonstrated efficacy of 97.6%, based on the analysis of data on the infection rate of...

Full Article